How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market
- By Product Type: Film Adhesion Barriers, Gel Adhesion Barriers, Spray Adhesion Barriers, Powder Adhesion Barriers
- By Material Composition: Hyaluronic Acid-Based, Carboxymethylcellulose-Based, Polylactic Acid-Based, Oxidized Regenerated Cellulose-Based, Polyethylene Glycol-Based
- By Application Method: Laparoscopic Application, Open Surgery Application, Robotic Surgery Application
- By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
- By Surgical Procedure: Gynecological Surgery, General Surgery, Urological Surgery, Colorectal Surgery
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Film Adhesion Barriers leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Material Composition 5
Application Method 3
End-User 3
Surgical Procedure 4
Companies profiled
Baxter International Inc.
Ethicon (Johnson & Johnson)
B. Braun Melsungen AG
C.R. Bard (now part of BD)
Medtronic plc
Hyaltech Ltd.
FzioMed Inc.
GEM Biomedical Inc.
SurgiMend (TEI Biosciences)
Integra LifeSciences Corporation
Polymed Medical Devices
Aesculap AG (B. Braun)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Ethicon (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →C.R. Bard (now part of BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Hyaltech Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →FzioMed Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →GEM Biomedical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →SurgiMend (TEI Biosciences)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Integra LifeSciences Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Polymed Medical Devices
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Aesculap AG (B. Braun)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Confluent Surgical Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →SurgiSeal Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →ClearPath Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,310M by 2033 · 10.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Film Adhesion Barriers53.6
- Gel Adhesion Barriers18.8
- Spray Adhesion Barriers11.8
- Powder Adhesion Barriers15.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$955.4M → $1,934M · 9.2%
Europe$665.9M → $1,435M · 10.1%
Asia Pacific$608.0M → $1,321M · 10.2%
Latin America$376.4M → $773.8M · 9.4%
Middle East and Africa$289.5M → $693.4M · 11.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.182026
10.192027
10.212028
10.222029
10.232030
10.242031
10.252032
10.262033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Baxter International Inc.18.3
- Ethicon (Johnson & Johnson)14.7
- B. Braun Melsungen AG11.3
- C.R. Bard (now part of BD)5.7
- Medtronic plc11.5
- Hyaltech Ltd.10.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type32.1%
Material Composition9.4%
Application Method21.5%
End-User14.6%
Surgical Procedure22.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.4
- Europe23.3
- Asia Pacific21.5
- Latin America12.6
- Middle East and Africa11.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Baxter International Inc. | 92 | 81 | 97 | 74 | 83 | 97 | 87 |
| Ethicon (Johnson & Johnson) | 75 | 68 | 69 | 86 | 71 | 75 | 74 |
| B. Braun Melsungen AG | 70 | 70 | 86 | 81 | 78 | 75 | 77 |
| C.R. Bard (now part of BD) | 64 | 70 | 79 | 81 | 63 | 68 | 71 |
| Medtronic plc | 65 | 54 | 76 | 73 | 74 | 68 | 68 |
| Hyaltech Ltd. | 69 | 52 | 52 | 50 | 53 | 68 | 57 |
| FzioMed Inc. | 55 | 52 | 63 | 43 | 64 | 45 | 54 |
| GEM Biomedical Inc. | 52 | 57 | 44 | 40 | 40 | 47 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Baxter International Inc.
- Ethicon (Johnson & Johnson)
- B. Braun Melsungen AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Baxter International Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Ethicon (Johnson & Johnson) | ✓ | − | ◐ | ◐ | ◐ | ◐ |
| B. Braun Melsungen AG | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| C.R. Bard (now part of BD) | − | ✓ | ◐ | ◐ | ✓ | ✓ |
| Medtronic plc | − | − | ◐ | ✓ | ◐ | ◐ |
| Hyaltech Ltd. | − | − | − | ◐ | ◐ | ✓ |
| FzioMed Inc. | − | − | − | ◐ | ◐ | ◐ |
| GEM Biomedical Inc. | − | ◐ | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Baxter International Inc.87
2B. Braun Melsungen AG77
3Ethicon (Johnson & Johnson)74
4C.R. Bard (now part of BD)71
5Medtronic plc68
6Hyaltech Ltd.57
7FzioMed Inc.54
8GEM Biomedical Inc.47
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Baxter International Inc.
Challenger4
Strong scale, closing on the leaders.
Ethicon (Johnson & Johnson)B. Braun Melsungen AGC.R. Bard (now part of BD)Medtronic plc
Contender1
Focused players with pockets of strength.
Hyaltech Ltd.
Niche2
Specialists in a single segment or region.
FzioMed Inc.GEM Biomedical Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market — a $412M beachhead inside a $5.99B market.
Beachhead (SOM)$412Mobtainable near-term
Serviceable (SAM)$2.34Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Film Adhesion Barriers
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Gel Adhesion Barriers
Strong fit — clear ROI and a fast path to value.
End user69 fit
Spray Adhesion Barriers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material Composition & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application Method
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified26%
Evaluation14%
Closed-won7%
$19.6KCAC
$92KLTV
4.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market is a resilient opportunity — $4.02B by 2033, compounding at 4.5%.
TAM · 2025$2.84Btoday
TAM · 2033$4.02Bforecast
CAGR4.5%2027–2033
Cumulative$30.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.02BTotal addressable market
SAM$1.44BServiceable available market
SOM$255MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.02BLarge & growingTAM by 2033 at 4.5% CAGR
$1.44BServiceable nowreachable with today’s model
$255MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.14BBear2.9% CAGR
$4.02BBase4.5% CAGR
$5.15BBull5.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material Composition optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market — a $7.91B market by 2033. Plan: grow share from 8.9% to 14.4%.
Market size · 2033$7.91Btotal addressable
Market CAGR10.6%2027–2033
Target share14.4%from 8.9% today
Revenue ambition$1.14Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.9% | 14.4% | On track |
| Revenue | $764M | $1.14B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.7% | 38.4% | Ahead |
| Customer retention | 84.4% | 94.6% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material Composition capability
A defensible second engine — invest in Material Composition to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material Composition
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $124M capacity & capability investment
- Greenlight bolt-on M&A in Material Composition
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market conversation — a $4.65B market you can size, segment and defend in minutes.
Market size · 2033$4.65Btotal opportunity
Growth10.7%CAGR to 2033
Addressable buyers910+accounts in scope
Typical ROI6.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.4×return on cost, year one
< 4 mopayback period
$73K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Baxter International Inc.Ethicon (Johnson & Johnson)B. Braun Melsungen AGC.R. Bard (now part of BD)Medtronic plcHyaltech Ltd.FzioMed Inc.GEM Biomedical Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Prevention and Treatment of Intraperitoneal Adhesion Barrier Materials After Surgery Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Preventer Asthma Inhaler Market
Market size, share, segmentation and regional forecast.
$624M market · 2025 base year
View reportPrevacuum Sterilizers Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportPre-vacuum Autoclave Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportPreterm Birth Prevention and Treatment Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportPreterm Birth Prevention and Management Market
Market size, share, segmentation and regional forecast.
$312M market · 2025 base year
View reportPreterm Birth and PROM Testing Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPre-Surgery Shaver Market
Market size, share, segmentation and regional forecast.
$885M market · 2025 base year
View reportPrestige Cervical Disc Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportPrestained Protein Standard Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportPressurized Cold Therapy System Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportPressureWire for FFR Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportPressureWire and Pressure Microcatheter for FFR Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.